Search Results - "MÉNARD, J. F."

Refine Results
  1. 1

    Hyperprolinemia is a risk factor for schizoaffective disorder by JACQUET, H, DEMILY, C, BELLEGOU, C, FOULDRIN, G, DELAMILLIEURE, P, MENARD, J. F, DOLLFUS, S, D'AMATO, T, PETIT, M, THIBAUT, F, FREBOURG, T, CAMPION, D, HOUY, E, HECKETSWEILER, B, BOU, J, RAUX, G, LEROND, J, ALLIO, G, HAOUZIR, S, TILLAUX, A

    Published in Molecular psychiatry (01-05-2005)
    “…DNA sequence variations within the 22q11 DiGeorge chromosomal region are likely to confer susceptibility to psychotic disorders. In a previous report, we…”
    Get full text
    Journal Article
  2. 2

    Prognostic factors to succeed in surgical treatment of chronic acromioclavicular dislocations by Barth, J, Duparc, F, Baverel, L, Bahurel, J, Toussaint, B, Bertiaux, S, Clavert, P, Gastaud, O, Brassart, N, Beaudouin, E, De Mourgues, P, Berne, D, Duport, M, Najihi, N, Boyer, P, Faivre, B, Meyer, A, Nourissat, G, Poulain, S, Bruchou, F, Ménard, J.F

    “…Abstract Introduction Treatment of chronic acromioclavicular joint dislocation (ACJD) remains a poorly known and controversial subject. Given the many surgical…”
    Get full text
    Journal Article
  3. 3

    Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three‐year prospective study in community‐recruited patients by Vittecoq, O., Pouplin, S., Krzanowska, K., Jouen‐Beades, F., Ménard, J. F., Gayet, A., Daragon, A., Tron, F., Le Loët, X.

    Published in Rheumatology (Oxford, England) (01-08-2003)
    “…Objective. To evaluate the predictive value of clinical, biological and radiological parameters for the prognosis of rheumatoid arthritis (RA) in a…”
    Get full text
    Journal Article
  4. 4

    Short‐term and long‐term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients by Marie, I., Hatron, P. Y., Dominique, S., Cherin, P., Mouthon, L., Menard, J.‐F.

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-11-2011)
    “…Objective This study was undertaken to assess the characteristics and outcome of interstitial lung disease (ILD) in polymyositis/dermatomyositis (PM/DM) and to…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Impact of Three Anti-TNFα Biologics on Existing and Emergent Autoimmunity in Rheumatoid Arthritis and Spondylarthropathy Patients by Bacquet-Deschryver, H., Jouen, F., Quillard, M., Ménard, J. F., Goëb, V., Lequerré, T., Mejjad, O., Daragon, A., Tron, F., Le Loët, X., Vittecoq, O.

    Published in Journal of clinical immunology (01-09-2008)
    “…Objective The objective of this study was to analyze the effects of 3 anti-TNFα agents on markers of autoimmunity in rheumatoid arthritis (RA) and…”
    Get full text
    Journal Article
  7. 7

    Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome by Marie, I, Dominique, S, Janvresse, A, Levesque, H, Menard, J.-F

    Published in Respiratory medicine (01-04-2012)
    “…Summary Objective To report our experience using rituximab as therapy for refractory antisynthetase syndrome (ASS)-associated interstitial lung disease…”
    Get full text
    Journal Article
  8. 8

    Fecal calprotectin in systemic sclerosis and review of the literature by Marie, I, Leroi, A.-M, Menard, J.-F, Levesque, H, Quillard, M, Ducrotte, P

    Published in Autoimmunity reviews (01-06-2015)
    “…Abstract Fecal calprotectin (FC) is a simple, non-invasive and reproducible test, which has been described to be highly elevated in patients with active…”
    Get full text
    Journal Article
  9. 9

    Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome by Marie, I, Josse, S, Decaux, O, Dominique, S, Diot, E, Landron, C, Roblot, P, Jouneau, S, Hatron, P.Y, Tiev, K.P, Vittecoq, O, Noel, D, Mouthon, L, Menard, J.-F, Jouen, F

    Published in Autoimmunity reviews (01-08-2012)
    “…Abstract The aims of the present study were to: compare the characteristics between antisynthetase syndrome (ASS) patients with anti-Jo1 antibody and those…”
    Get full text
    Journal Article
  10. 10

    Intravenous immunoglobulins for steroid‐refractory esophageal involvement related to polymyositis and dermatomyositis: A series of 73 patients by Marie, I., Menard, J.‐F., Hatron, P. Y., Hachulla, E., Mouthon, L., Tiev, K., Ducrotte, P., Cherin, P.

    Published in Arthritis care & research (2010) (01-12-2010)
    “…Objective To assess the long‐term outcome of esophageal complications in the group of patients receiving intravenous immunoglobulins (IVIG) for the treatment…”
    Get full text
    Journal Article
  11. 11

    Interstitial Lung Disease in Anti–Jo‐1 Patients With Antisynthetase Syndrome by Marie, I., Josse, S., Hatron, P. Y., Dominique, S., Hachulla, E., Janvresse, A., Cherin, P., Mouthon, L., Vittecoq, O., Menard, J.‐F., Jouen, F.

    Published in Arthritis care & research (2010) (01-05-2013)
    “…Objective To assess the outcome of interstitial lung disease (ILD) in anti–Jo‐1 patients with antisynthetase syndrome, determine predictive variables of ILD…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Transcutaneous Electrical Tibial Nerve Stimulation in the Treatment of Fecal Incontinence: A Randomized Trial (Consort 1a) by LEROI, A. M, SIPROUDHIS, L, ROUMEGUERE, P, GOURCEROL, G, BOUVIER, M, LALLOUCHE, K, MENARD, J. F, QUERALTO, M, ETIENNEY, I, DAMON, H, ZERBIB, F, AMARENCO, G, VITTON, V, FAUCHERON, J. L, THOMAS, C, MION, F

    Published in The American journal of gastroenterology (01-12-2012)
    “…The objective of this study was to show that although transcutaneous electrical tibial nerve stimulation (TENS) is being increasingly used to treat fecal…”
    Get full text
    Journal Article
  14. 14

    Long term outcome of patients with low level of cryoglobulin (< 0.05 g/L) by Eble, V, Legallicier, B, Joly, P, Vittecoq, O, Caron, F, Tamion, F, Ducrotte, P, Levesque, H, Menard, J.-F, Jouen, F, Guerrot, D, Marie, I

    Published in Autoimmunity reviews (01-05-2016)
    “…Abstract Objectives To date, no studies have yet assessed the characteristics of non-HCV patients with low level of cryoglobulin (≤ 0.05 g/L). The aims of the…”
    Get full text
    Journal Article
  15. 15

    Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome by Marie, I, Josse, S, Decaux, O, Diot, E, Landron, C, Roblot, P, Jouneau, S, Hatron, P.Y, Hachulla, E, Vittecoq, O, Menard, J.-F, Jouen, F, Dominique, S

    Published in European journal of internal medicine (01-07-2013)
    “…Abstract Background The aims of the present study were to determine both clinical manifestations and outcome of anti-PL7 patients with antisynthetase syndrome…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Lactose malabsorption in systemic sclerosis by Marie, I., Leroi, A‐M., Gourcerol, G., Levesque, H., Menard, JF., Ducrotte, P.

    “…Summary Background There are no studies on systemic sclerosis (SSc) assessing the relationship between food intake, especially lactose, and gastrointestinal…”
    Get full text
    Journal Article
  18. 18

    Risk factors of vitamin K antagonist overcoagulation by Marie, I., Leprince, P., Menard, J.-F., Tharasse, C., Levesque, H.

    Published in QJM : An International Journal of Medicine (01-01-2012)
    “…Objectives: The aims of this prospective study were to identify, in vitamin K antagonist (VKA)-treated patients, factors associated with INR values: (i)…”
    Get full text
    Journal Article
  19. 19

    Saccadic and smooth-pursuit eye movements in deficit and non-deficit schizophrenia by Nkam, I., Thibaut, F., Denise, P., Van Der Elst, A., Ségard, L., Brazo, P., Ménard, J.-F., Théry, S., Halbeck, I., Delamilleure, P., Vasse, T., Etard, O., Dollfus, S., Champion, D., Levillain, D., Petit, M.

    Published in Schizophrenia research (01-03-2001)
    “…We have analyzed eye movement performances in schizophrenics showing primary negative or deficit symptoms ( n=16) and non-deficit schizophrenics ( n=55), and…”
    Get full text
    Journal Article
  20. 20

    Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab by Lequerré, T., Jouen, F., Brazier, M., Clayssens, S., Klemmer, N., Ménard, J.-F., Mejjad, O., Daragon, A., Tron, F., Le Loët, X., Vittecoq, O.

    Published in Rheumatology (01-03-2007)
    “…Objectives. To identify biochemical, immunological and bone markers as predictors of rheumatoid arthritis (RA) patients' responses to infliximab. Methods. A…”
    Get full text
    Journal Article